Healthcare DIVE November 6, 2024
Rebecca Pifer

An unsuccessful struggle with elevated medical costs has defined 2024 for CVS. The third quarter was no different.

Dive Brief:

  • CVS reported mixed third-quarter results shadowed by heightened medical costs on Wednesday, in the massive healthcare enterprise’s first earnings report with new CEO David Joyner at the helm.
  • The Woonsocket, Rhode Island-based company beat Wall Street expectations on revenue of $95.4 billion, up more than 6% year over year. However, CVS’ net income fell to $71 million, down from almost $2.3 billion same time last year, as its Aetna insurance arm continued to struggle with higher spending.
  • CVS appointed Steve Nelson, previously the CEO of value-based primary care company ChenMed, as president of Aetna. Nelson also ran UnitedHealthcare, the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Payer
20 payer executives' top priorities for 2025
6 GI payer updates in 2024, where they stand now
Health-care stocks fall as lawmakers, patients push for changes to their business models
These Entrepreneurs Are Using AI To Fight Health Insurance Claims Denials
Enhabit CEO On Company’s New Home Health Agreement With UnitedHealthcare

Share This Article